Dr. Tabassum Asif Khan

M. Pharm. Ph.D.

Area of Specialization    

Pharmaceutical Chemistry and Quality Assurance

Experience            

Academics: 23 Years

Industry: 04 Years

Interest areas    

Medicinal Chemistry (Synthetic and natural products), Pharmaceutical Analysis and Nanotechnology

Awards:

SHASTRI FELLOW- Shastri Indo-Canadian Institute (SICI), Shastri Mobility Programme (SMP) fellowship award for the year 2017-18, March 2018.

P. D. Sethi National award for best research paper (third position) published in 2016 on HPTLC, October 2017.

Publications:

Publications: 50

Books/Book chapters: 01/05

Google Scholar link: https://scholar.google.com/citations?user=P-gVpiUAAAAJ&hl=en

ORCiD link: https://orcid.org/0000-0002-3723-0833

Recent Publications

1. Gaikwad S and Khan T. Phytochemistry and antibacterial activity of traditional medicinal plant Ziziphus rugosa LAM. Indian Drugs, 2023, 60 (03): 40-46. Scopus indexed.
2. Tiwari D & Khan Tabassum, “Phytochemical screening, antioxidant and anti-inflammatory activity of Litsea ghatica stem bark” Indian Drugs, January 2023, 60 (01): 44-49, Scopus indexed
3. Singh Prabha; Waghambare P; Khan Tabassum & Omri A, Colorectal cancer management: strategies in drug delivery, Expert opinion on Drug Delivery, July
   2022, 19(6), 653-670(IF: 6.648) DOI: 10.1080/17425247.2022.2084531
4. Desai D; Patil S & Khan Tabassum, Functionalisation of polysaccharides versatile strategies and their applications, International Journal of Pharmaceutical Sciences & Research, July 2022, 13(7), 2587-2601. DOI: 10.13040/IJPSR.0975-8232.13(7).2587-01
5. Nadar S; Khan Tabassum & Omri A, Reemergence of monkeypox: prevention and Management, Expert Review of Anti-infective Therapy, September 2022, 22(11), 1425-1433(IF:5.854) DOI:10.1080/14787210.2022.2128763
6. Mansi Damani, Neha Desai, Bheeshma Pratap Singh, Raghumani Singh Ningthoujam, Munira Momin, Tabassum Khan, Synthesis of Hollow Gold Nanoparticles - Impact of Variables on Process Optimization,
   Journal of Pharmaceutical Sciences, 111 (10), 2022, 2907-2916 (ISSN 0022-3549) 
   DOI: https://doi.org/10.1016/j.xphs.2022.08.003 (IF = 3.784)
7. Jethva P, Momin M, Khan T, Omri A. Lanthanide-Doped Upconversion Luminescent Nanoparticles-Evolving Role in Bioimaging, Biosensing, and Drug Delivery. Materials (Basel). 2022 Mar 23;15(7):2374. doi: 10.3390/ma15072374 (IF = 3.748)
8. Nair A, Mallya R, Suvarna V, Khan TA, Momin M, Omri A. Nanoparticles-Attractive Carriers of Antimicrobial Essential Oils. Antibiotics (Basel). 2022 Jan 14;11(1):108. doi: 10.3390/antibiotics11010108. (IF = 5.222)
9. Vaibhavi Sonetha, Sharmi Majumdar, Soham Shah, Munira Momin, Tabassum Khan, Step-wise micro-fabrication techniques of microneedle arrays with applications in transdermal drug delivery, Journal of Drug Delivery Science and Technology, Volume 68, February 2022, 103119.
10. Nadar S & Khan Tabassum, Pyrimidine: An elite heterocyclic leitmotif in drug discovery-synthesis and biological activity Chemical Biology & Drug Design, November 2022, 100(6), 818-842(IF: 2.873) Review article. 10.1111/cbdd.14001
11. M Quadros, M Momin, G Verma, Implications of Synthesis Methodology on Physicochemical and Biological Properties of Hydroxyapatite, Handbook on Synthesis Strategies for Advanced Materials, 617-658: Book chapter.
12. Shaikh J; Patel Kavit & Khan Tabassum, Advances in pyrazole based scaffold as cyclin-dependent kinase 2 inhibitors for the treatment of cancer, Mini Reviews in  Medicinal Chemistry, 2022, 22(8), 1211-1229 (IF =3.862) DOI: 10.2174/1389557521666211027104957
13. Nadar S; Khan Tabassum; Patching S and Omri A, Development of Antibiofilm Therapeutics Strategies to Overcome Antimicrobial Drug Resistance. Microorganisms, January 2022, 10(2), 10020303(IF: 4.128) DOI:10.3390/microorganisms10020303
14. Gaikwad S & Khan Tabassum, A phyto pharmacological review on traditional medicinal plant ziziphus rugosa lam, International Journal of Pharmaceutical Sciences and Research, April  2022, 13(4), 1456-1462 (Scopus Indexed) Review article. 10.13040/IJPSR.0975-8232.13(4).1456-62
15. Suvarna Vasanti; Nair A; Mallya Rashmi; Khan Tabassum and Omri A, Antimicrobial nanomaterials for food packaging, Antibiotics, May 2022, 11(6), 1-31(IF: 4.6) DOI: https://doi.org/10.3390/antibiotics11060729
16. Jadeja K; Khambete M & Khan Tabassum, Phosphodiesterase (pde) inhibitors in alzheimer’s disease: role and current status, Indian Drugs, June 2022, 59(5), 7-16 (Scopus Indexed) Review article. https://doi.org/10.53879/id.59.05.12860

Patents:

Granted: Nil

Published: 03

Filed with complete specifications: 03

Research/ Sponsored projects:

Government: 07; Funding: 2.51 Crore

Industry: 02; Funding: 2.0 Lac

Invited talks: 15

Research students:

M. Pharm: 25

Ph. D: 05

Conferences attended: 25

Workshops attended: 20

Seminars attended: 35

Paper Presentations: 50

Professional memberships:

Indian Pharmaceutical Association

Society of Pharmaceutical Education and Research

American Association of Pharmaceutical Scientists

International Pharmaceutical Federation 

Contact details:

E-mail: tabassum.khan@bncp.ac.in

Tel. 022-4233 2052 (Ext 2066)

https://in.linkedin.com/in/tabassum-khan-7262551a6

Dr. Arati Prabhu

M. Pharm. Ph.D.

Area of Specialization
Pharmaceutical Chemistry and Quality Assurance

Experience:

Academics- 11 Years
Industry- 12 Years

Thrust Research areas
Computer aided Drug Design (CADD), Drug Discovery

Awards

Publications:

Publications: 26

Books/Book chapters: 1 book chapter

Google Scholar link:

https://scholar.google.com/citations?hl=en&user=wn97iZ8AAAAJ&view_op=list_works&sortby=pubdate

ORCiD link: https://orcid.org/my-orcid?orcid=0000-0003-3637-8964

Recent Publications 

1. Punmiya A, Prabhu A* "Structural fingerprinting of pleiotropic flavonoids for multifaceted Alzheimer’s disease" Neurochemistry International 2023; 163, 105486. IF= 4.297 
2. Borkar M., Prabhu, A, Kanugo A, Rupesh Gautam: Book chapter on "Pharmacophore modeling" in book titled, “Computational approaches in Drug Discovery, Development and Systems Pharmacology” ISBN: 9780323991377 (Elsevier) 
3. Udipi S A, Joshi J, Singh G, Sawarkar S, Phadke, A, Prabhu A, Rastogi, N,  Vaidya A B. Phytoactives as chelators of iron with potential to mitigate its side effects and enhance iron absorption. Int J Pharm Sci Res. 2022; 13 (8): 3078–102. Pise N, Prabhu A*, Raheja R and Dhala I, "Therapeutic Peptides: Unravelling Conformational Dynamics by Systematic Application of Biophysical Techniques” Current Protein & Peptide Science 2022; 23 (9), 619-641. IF= 3.272  
4. Illham Dhala, Tabassum Khan, Arati Prabhu. “Natural Chimeras of Existing Drugs for Alzheimer’s Disease: Expanding the Target Landscape” Indian Journal of Pharmaceutical Education and Research 55 (1), 2021, S29 – 47 (IF: 0.531)  
5. Kaksha Sankhe, Arati Prabhu, Tabassum Khan, “Design strategies, SAR, and mechanistic insight of Aurora kinase inhibitors in cancer” Chemical Biology and Drug Design (2021), 98(1), 73-93 (IF: 2.873)  
6. Book chapter on ‘Chimeric Conjugates for Alzheimer’s Disease’ by Illham Dhala, Tabassum Khan, Arati Prabhu in ‘Alzheimer’s Disease: Drug Discovery.’ Pp 165 - 180 Huang X (Editor). Exon Publications, Brisbane, Australia ISBN: 978-0-6450017-0-9; doi: https://doi.org/10.36255/exonpublications.alzheimersdisease.2020 
7. Jadhav M., Prabhu A* "Metallic and polymeric green nanoplatforms in oncology" J. Applied Microbiology 2022; 134, 1-19 (IF= 4.061)
8. Abstract titled “Punmiya A, Gharat R, Prabhu A. Development of Bioactive Molecules for the Treatment of Alzheimer’s Disease. Med Sci Forum. 2022;14(1):7. (MDPI Conference proceedings)  
9. Abstract titled “Pise NP, Prabhu A, Raheja R. Forced Degradation Studies on Agents of Therapeutic Interest. Med Sci Forum;14(1):22 (MDPI Conference proceedings)Pimpale Prachi; Singh Prabha; Prabhu Arati & Gupta S, Development and optimization of HP-ß-CD inclusion complex-based fast orally disintegrating tablet of pitavastatin calcium, Journal of Pharmaceutical Innovation, 2022, 17,  993-1010 DOI: https://doi.org/10.1007/s12247-022-09661-x (IF= 2.538).
10. Pise N; Prabhu Arati; Raheja Radhika and Dhala I, Therapeutic Peptides: Unravelling Conformational Dynamics by Systematic Application of Biophysical Techniques, Current Protein & Peptide Science, 2022, 23(9), 619-641. DOI: 10.2174/1389203723666220908150054 (IF= 3.272).
11. Dixit G & Prabhu Arati, The pleiotropic peroxisome proliferator activated receptors: Regulation and therapeutics, Experimental & Molecular Pathology, 2022, 124, 104723. DOI: https://doi.org/10.1016/j.yexmp.2021.104723 (IF= 4.4.01).
12. Patel M & Prabhu Arati, Smart nanocomposite assemblies for multimodal cancer theranostics, International Journal of Pharmaceutics, 2022, 618, 1-15 DOI: https://doi.org/10.1016/j.ijpharm.2022.121697 (IF= 5.875).
13. Gharat R; Prabhu Arati & Khambete M, Potential of triazines in Alzheimer’s disease: a versatile scaffold, Archiv der Pharmazie, 2022, 355, 2100388. DOI: DOI: 10.1002/ardp.202100388  (IF= 3.751)

Patents: 01 (Granted)

Research / Sponsored projects:
Government: 2 (INR 8,50,000.00)
Industry: 2 (INR 1,80,000.00) 

Invited Speaker / Judge: 11

Research students guided: 

Paper presentations: 06

Professional memberships
Life member of NMR Society (NMRS, India)
Registered Pharmacist, Maharashtra State Pharmacy Council 
Life-member of Association of Pharmaceutical Teachers of India
Life-member of Indian Pharmaceutical Association

Contact details:

Dr. Vasanti Suvarna

M. Pharm. Ph. D.

Specialization: Pharmaceutical Chemistry & Quality Assurance

Experience: 
Teaching: 17 years 
Industry: 02 Years 

Thrust research areas: Solubility enhancement, drug discovery, analytical method development, natural products research

Publications: 

Publications: 46 

Cumulative impact factor of Clarivate/ Thompson Reuter: 65.257

Books/Book chapters: 9 

Google Scholar link: https://scholar.google.com/citations?hl=en&user=pfVNg7sAAAAJ

ORCiD link: https://orcid.org/0000-0002-5340-723X

Recent Publications-

1. Suvarna Vasanti; Sawant Niserga & Desai N, “A review on recent advances in mannose functionalized nanocarriers for targeted delivery in cancer and infective therapeutics” Critical Reviews™ in Therapeutic Drug Carrier Systems 2023, 40(2), pp. 43-82 (IF:4.889)
2. Suwarna Vasanti; Raut A, “ Analytical Methods For the Determination of Atypical Antipsychotic Drugs - An Update “,  Current Analytical Chemistry 2023, 19(2), 147 – 175(IF: 2.374)
3. Suvarna Vasanti; Bore B; Bhawar C; Mallya Rashmi, Complexation of phytochemicals with cyclodextrins and their derivatives-an update, Biomedicine & Pharmacotherapy March 2022, 149, 1-28 (IF: 6.529) DOI: https://doi.org/10.1016/j.biopha.2022.112862
4. Momin Munira; Khan Tabassum; Malliya Rashmi; Suvarna Vasanti; Omri A& Nair A, Nanoparticles—attractive carriers of antimicrobial essential oils, Antibiotics, 2022, 11(1), 108 (IF: 4.63) DOI: 10.3390/antibiotics11010108.
5. Bhawar C; Suvarna Vasanti & Mallya Rashmi, Simultaneous estimation of Naproxen and Famotidine by analytical Q absorption ratio method, International Journal of Pharmacy and Pharmaceutical Research. 2022, 24(4), 264-273.Research article https://ijppr.humanjournals.com/simultaneous-estimation-of-naproxen-and-famotidine-by-analytical-q-absorption-ratio-method/
6. Suvarna Vasanti; Nair A; Mallya Rashmi; Khan Tabassum and Omri A, Antimicrobial nanomaterials for food packaging, Antibiotics, May 2022, 11(6), 1-31(IF : 4.6) DOI: https://doi.org/10.3390/antibiotics11060729.
7. Mundada S; Mallya Rashmi & Suvarna Vasanti, Formulation and evaluation of polyherbal vermifuge suspension. Science, Technology and Development, September 2022, 9(9), 394-402. Research article
   Shinde R; Suvarna Vasanti & Abhyankar Arundhati, An insight into privileged scaffolds in tuberculosis: developmental aspects and implications in drug design. Indian Drugs, January 2022, 59(1), 7-22(IF: 0.126) DOI: https://doi.org/10.53879/id.59.01.13140
8. Chamriya R; Raheja Radhika; Suvarna Vasanti & Bhandare R, A critical review on phytopharmacology, spectral and computational analysis of phytoconstituents from Streblus asper Lour, Phytomedicine Plus, 2022, 2(1), 100177 (Scopus Indexed) DOI: https://doi.org/10.1016/j.phyplu.2021.100177
9. Suvarna Vasanti Deshmukh K & Murahari M, miRNA and antisense oligonucleotide-based a-synuclein targeting as disease-modifying therapeutics in Parkinson’s disease, Frontiers in Pharmacology, November 2022, 13,1034072 (IF: 5.988) DOI: 10.3389/fphar.2022.1034072.
10. Suvarna Vasanti; Sawant N & Desai N, A review on recent advances in mannose functionalized nanocarriers for targeted delivery in cancer and infective therapeutics. Critical Reviews™ in Therapeutic Drug Carrier Systems, December 2022, 40(2), 43-82.  (IF: 4.889) DOI:10.1615/CritRevTherDrugCarrierSyst.2022041853
11. Suvarna Vasanti & Chippa S, Current Overview of Cyclodextrin Inclusion Complexes of Volatile Oils and their Constituents Current Drug Delivery. 2022, 1-21 (IF: 3.758) Online ahead of print.  10.2174/1567201819666220630121939
12. Suvarna Vasanti; Gujar P; Murahari M; Sharma D & Chamariya R, Supramolecular ternary inclusion complexes of irbesartan with hydroxypropyl-beta-cyclodextrin. Journal of Drug Delivery Science and Technology, January 2022, 67, 1-11(3.981) DOI: https://doi.org/10.1016/j.jddst.2021.102964
13. Shinde R and Suvarna Vasanti, Fatty Acid Biosynthesis: An Updated Review on KAS Inhibitors, Current Drug Discovery Technologies, February 2022, 19(2), 1-15. DOI: 10.2174/1570163819666220111113032
14. Chamariya R& Suvarna Vasanti, Role of KSP inhibitors as anti-cancer an update
    Anti-cancer Agents in Medicinal Chemistry, April 2022, 22(14), 2517-2538(2.505) DOI:10.2174/1871520622666220119093105.

Research/ Sponsored Projects: 
- Government: 4 (INR 98,000.00
- Industry: 3 (INR. 1,33,340.00)

Research students guided:

M. Pharm- 23

Conferences attended: 20
Workshops attended: 15
Seminars attended: 48
Paper Presentations: 18

Professional membership
- Life member of Indian Pharmaceutical Association (IPA)
-  Life member of Indian Society for Technical Education(ISTE) 

Contact details:

E-mail: vasanti.suvarna@bncp.ac.in

Tel. 022-4233 2052 (Ext 2065 )

LinkedIn Profile: 

https://www.linkedin.com/search/results/people/?network=%5B%22F%22%5D&origin=MEMBER_PROFILE_CANNED_SEARCH&sid=Pwc

Dr. Radhika Raheja

M. Pharm. Ph. D.

 Area of Specialization: Pharmaceutical Chemistry 

Experience: 
Academic: 26 Years 

Thrust research areas:   

Awards: 

First Prize in "AVISHKAR-2010" 5^thInter-University Research Festival conducted by Maharashtra University ofHealth Sciences, Nashik

Publications:

Publications: 6

Books/Book chapters: 1

Google Scholar link: https://scholar.google.com/citations?user=KGuh1vgAAAAJ&hl=en

ORCiD link: https://orcid.org/0000-0003-3372-0664

Recent publications:

1. Pise N; Prabhu Arati,  Raheja Radhika and Dhala I, Therapeutic Peptides: Unravelling Conformational Dynamics by Systematic Application of Biophysical Techniques, Current Protein & Peptide Science, October 2022, 23(9), 619-641(IF: 3.272) DOI: 10.2174/1389203723666220908150054
2. Fuloria N; Raheja Radhika; Shah K; Oza Manisha; Kulkarni Y; Subramaniyan V; Sekar M and Fuloria S, Biological activities of meroterpenoids isolated from different sources, Frontiers in Pharmacology, September 2022, 1-36 (IF: 5.988), DOI: 10.3389/fphar.2022.830103
3. Chamriya R; Raheja Radhika; Suvarna Vasanti & Bhandare R, A critical review on phytopharmacology, spectral and computational analysis of phytoconstituents from Streblus asper Lour, Phytomedicine Plus, February 2022, 2(1), 100177. (Scopus indexed) DOI:https://doi.org/10.1016/j.phyplu.2021.100177
4. Govindarao K; Srinivasan N; Suresh R; Raheja Radhika Annadurai S;  Bhandare R  Shaik A, Quinoline conjugated 2-azetidinone derivatives as prospective anti-breast cancer agents: In vitro antiproliferative and anti-EGFR activities, molecular docking and in-silico drug likeliness studies, Journal of Saudi Chemical Society, May 2022, 26(3), 101471 (IF: 3.932) DOI: https://doi.org/10.1016/j.jscs.2022.101471
5. Nailwal N; Bhatia N; Ali A;Ansari A; Raheja Radhika ; Godad Angel & Doshi Gaurav, in the book published, Marine Antioxidants, Marine Antioxidants Preparations, Syntheses, and Applications, ISBN 978-0-323-95086-2, Elsevier.   https://www.sciencedirect.com/science/article/pii/B9780323950862000114?via%3Dihub (Book Chapter)

Research/ Sponsored projects:

International collaboration: 01

Research students guided: 

M. Pharm- 5

Conferences attended: 10

Workshops attended: 20

Seminars attended: 25

Paper Presentations: 07

Professional memberships:

- Life Member - Indian Association of Cancer Research
- Life member ‘Maharashtra State Pharmacy Council’
- Life member ‘Indian Pharmaceutical Association

’

Contact details: 

- E-mail: radhika.raheja.@bncp.ac.in

- Tel. 022-4233 2052 (Ext:2123)

Dr. Atul P. Sherje

M. Pharm. Ph. D.

Specialization: 

Pharmaceutical Chemistry Quality Assurance 

Experience: 

Academic- 17

Thrust research areas: 

Development and Validation of analytical methods Solubility enhancement of poorly water-soluble drugs 

Awards:

Received Third Prize in Avishkar Research Convention 2019-20 (University Level in Pharmacy and Medicine Category- PG Level) organized by University of Mumbai.

Received Best Research supervisor award in “4th Sanjivani Avishkar- 2020- A National level innovative research idea competition for budding scientist”, organized by SRES’s Sanjivani College of Pharmaceutical Education and Research, 15th March, 2020.

Awarded International travel grant form Department of Biotechnology, Govt. of India, for attending Asianl Federation of Pharmaceutical Sciences (AFPS Conference 2015 at Bangkok, Thailand in Nov, 2015.

First Position in Avishkar 2015 Research Convention (University Level of Teacher Category: Medicine and Pharmacy) organized by University of Mumbai.

Silver medal in M. Pharm. Part I & II examination (Quality Assurance) by Nagpur University in 2005.

Felicitation by NMIMS for contribution to designing the display of “NMIMS at a glance” for NAAC in 2017.

Special appreciation award by SVKM’s Dr. Bhanuben Nanavati College of Pharmacy “in recognition of contribution to designing artwork for the institute”, Feb 2018.

Publications:

Publications: 42

Books/Book chapters: 01

Google Scholar link: https://scholar.google.com/citations?user=QuL069MAAAAJ&hl=en

ORCiD link: https://orcid.org/my-orcid?orcid=0000-0001-7306-1646

Recent Publications

1. Bhatia NY, Jalgaonkar MP, Hargude AB, Sherje Atul; Oza Manisha & Doshi Gaurav, Gut-Brain Axis and Neurological Disorders-How Microbiomes Affect our Mental Health. CNS Neurological Disorder Drug Targets. August 2022(IF: 2.824) DOI:10.2174/1871527321666220822172039 Online ahead of print
2. Sherje Atul & Dias S, Development and validation of RP-HPLC method for determination of nortriptyline hydrochloride in bulk and dosage form Indian Drugs, August 2022, 75(08), 49-52. (Scopus Indexed) DOI: 10.53879/id.59.08.11384
3. Surendran G & Sherje Atul, Cellulose nanofibers and composites: An insight into basics and biomedical applications Journal of Drug Delivery Science & Technology September 2022, 75, 103601(IF:5.062) Review article. 
4. Mali P & Sherje Atul, Cellulose nanocrystals: fundamental and biomedical applications, Carbohydrate Polymers, January 2022, 275, 1-14(IF:9.381) Review article.   https://www.sciencedirect.com/science/article/abs/pii/S0144861721010559

Research/ Sponsored projects:

Government: 02 (3.80 Lacs)

Industry: 03 (1.35 Lacs)

Invited talk: 01

Research students guided:

M. Pharm: 25

Conferences attended: 15

Workshops attended: 20

Seminars attended: 11

Paper Presentations: 20

Professional Memberships:

Life Member of Association of Pharmaceutical Teachers of India (APTI)

Life member of Indian Society for Technical Education (ISTE) 

Life member of Indian Pharmaceutical association (IPA)

Contact Details:

E-mail: atul.sherje@bncp.ac.in

Tel. (O). 022- 4233 2052 (Ext. 2110)

Dr. Sandip Zine

M. Pharm. Ph. D.

Pharmaceutical Chemistry

Experience:

Academic- 16 years

Thrust research areas:   
Synthetic chemistry, analytical method development and Validation, phytochemical investigation

Awards:

1. Indian Drug Manufacturers association, Research award for the Best research paper publishedon topic “Characterization of 5-HT_1A receptor by QSAR studies onthe 5-HT_1A receptor antagonists” in the Indian Drugs Journal, on16^th January, 2009.
2. Awarded first prize for poster presentation on “Development of a Floating-Pulsatile Site-Specific Drug Delivery System for Chronotherapeutic Release of Aceclofenac” at Recent Advances in Chemical Engineering 2010, on 20^thMarch, 2010 at North Maharashtra University, Department of Chemical Technology, Jalgaon.
3. Best Paper Award (Oral Presentation) on topic “Advance digital pedagogical approaches in education” atNational Conference on Innovative Teaching & Exuberant Learning (nCiTeL)organized by Kalsekar Technical Campus, Panvel, Navi Mumbai.

Publications: 

Publications: 18

Books/Book chapters: 01

Google Scholar link: https://scholar.google.com/citations?user=KiXht6vyAlsC&hl=en

ORCiD link:https://orcid.org/0000-0001-9982-0014

Scopus link: https://id.elsevier.com/settings/closeChangeSettingsFeatureScreen?close=true

Recent Publications

1. Mhapankar N; Siddique A.; Doshi Gaurav; Godad Angel & Zine Sandip, Deciphering the Role of ß-Lactamase Inhibitors, Membrane Permeabilizers and Efflux Pump Inhibitors as Emerging Targets in Antibiotic Resistance. Indian Journal of Microbiology 2022, 62, 524-530 (IF: 2.21) DOI: https://link.springer.com/article/10.1007/s12088-022-01045-6
2. AntivirulenceTherapy- A Promising Alternative Technique for Antibiotic Resistance, Research& Reviews: A Journal of Bioinformatics, ISSN: 2393-8722, 7(3), 01-14.
3. Nitrosamine: The Carcinogenic Impurity in AngiotensinReceptor Blockers, Research & Reviews: Journal of Oncology andHematology, ISSN: 2319-3387, Volume 9, Issue 3, Page No. 36-43.

Trademark: 01

Research/Sponsored projects:

Government: 03 (INR 100000.00)

Invited talks: 07

Research students guided:

M. Pharm: 09

Ph. D: 01

Conferences attended: 25

Workshops attended: 05

Seminars attended: 40

Paper Presentations: 07

Professional memberships: 

Association of Pharmaceutical Teachers of India (APTI)

Maharashtra State Pharmacy Council (MSPC)

Contact details:

E-mail: sandip.zine@bncp.ac.in

Tel. 022-4233 2052

LinkedIn profile link: https://www.linkedin.com/in/sandip-zine-065344225

Dr. Kavitkumar N. Patel

M. Pharm. Ph.D.

Specialization:

Pharmaceutical Chemistry / Medicinal Chemistry

Experience:

Academic: 9 Years

Thrust Research Areas:

Medicinal Chemistry, Organic Chemistry, Computer Aided Drug Design; Drug design and synthesis of anti-tubercular and antibacterial drugs.

Awards:

- Awarded with Junior Research Fellowship (JRF) and Senior Research Fellowship(SRF) from University Grant Commission (UGC), Government of India for pursuing Ph.D.

- Awarded travel grant by DST and ICMR to attend Tetrahedron Symposium in Vienna,Austria 2013.

Publications:

Publications: 15

Recent Publications-

1. Shaikh J; Patel Kavit & Khan Tabassum, Advances in pyrazole-based scaffold as cyclin-dependent kinase 2 inhibitors for the treatment of cancer, Mini Reviews in Medicinal Chemistry, January 2022, 22(8), 1211-1229 (IF: 3.862) Review article. 10.2174/1389557521666211027104957
2. Shradha Bodkhe, Mayuri Nikam, Atul P. Sherje, Tabassum Khan, Vasanti Suvarna, Kavit Patel; Current insights on clinical efficacy of roflumilast for treatment of COPD, asthma and ACOS; International Immunopharmacology 88 (2020) 106906. (IF-3.943)
3. Dravyakar BR, Khedekar PB, Khan T, Sherje AP, Patel KN, Suvarna V.Design and Development of Novel 2-(Morpholinyl)-N-substituted Phenylquinazolin-4-amines as Selective COX-II Inhibitor. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2019; 18(1), 4-25.

Research/Sponsored projects:

Government: 1  (INR 30,000)

Industry: 1 (INR 40,000)

Conferences attended: 6

Workshops attended: 5

Seminars attended: 3

Paper Presentations: 4

Contact details:
E-mail: kavitkumar.patel@bncp.ac.in
Tel. (O): 022-4233 2052 (Ext. 2060)

Dr. Arundhati Nachiket Abhyankar

M. Pharm Ph. D

Specialization: Pharmaceutical Chemistry

Experience:  

Industry- 1 Year 1 Month 

Academics- 5 Years 

Thrust Research areas:

Design, Synthesis and Biological Evaluation of Anti-infective agent; Computer Aided Drug Design (CADD); Organic Chemistry; Medicinal Chemistry 

Awards: 

Publications/ Presentations:  

Research students guided: 

M. Pharm: 02

Contact details:

E-mail: Arundhati.abhyankar@bncp.ac.in

Tel. 022-4233 2052 (Ext 2060)

Ms. Prachi Pathak

Qualification: M. Pharm, Pursuing PhD

Specialization: Pharmaceutical Analysis

Dr. Prerna Waghmare

M. Pharm. Ph.D.

Ms. Afreen Khan

Qualification: M.Pharm. in Pharmaceutical Chemistry,

Designation: Assistant Professor

Kaksha Sankhe

Experience:

Academic: 3 years

Industry: NIL

Thrust research areas:  Medicinal Chemistry and Analytical Chemistry

Awards:

 2018: Qualified PET (PhD Entrance test)

2015: Qualified GPAT(graduate pharmacy aptitude test) http://www.gpat.in/.(AIR-1089)

2015: Qualified entrance test for National Institute of Pharmaceutical Education and Research (NIPER).http://www.niper.ac.in/(AIR 857)

Publications:
Publications: 5

Cumulativeimpact factor of Clarivate/ Thompson Reuter: 22.845

Books/Bookchapters: 1 (No. only)

GoogleScholar link: https://scholar.google.com/citations?user=b0LnWrUAAAAJ&hl=en

ORCiD link: https://orcid.org/0000-0002-3208-2608

Research/Sponsored projects:

Government: 1 

Conferencesattended: 6 

Workshopsattended: 4 

Seminarsattended: 4 

PaperPresentations: 4

Contactdetails:

E-mail: kakshavs@gmail.com

LinkedIn profile link: https://in.linkedin.com/in/kaksha-sankhe-8a8521125?original_referer=https%3A%2F%2Fwww.google.com%2F

List of publications:

Sankhe, K., Prabhu, A. and Khan, T., 2021. Design strategies, SAR, and mechanistic insight of Aurora kinase inhibitors in cancer. Chemical Biology & Drug Design, 98(1), pp.73-93.   https://doi.org/10.1111/cbdd.13850

Jadhav, M., Sankhe, K., Bhandare, R.R., Edis, Z., Bloukh, S.H. and Khan, T.A., 2021. Synthetic Strategies of Pyrimidine-Based Scaffolds as Aurora Kinase and Polo-like Kinase Inhibitors. Molecules, 26(17), p.5170. 10.3390/molecules26175170

Khan T, Sankhe K. DNA gyrase inhibitors. Encyclopedia of Molecular pharmacology. 2020

Sankhe K, Khan T, Trikha S, Sahu P.L. Synthesis and characterization of 6-hydroxy-3,4-dihydroquinolinone cilostazol impurity A as per Indian pharmacopeia. IJPSR. 2020.

Sankhe K, Khan T, Bhavsar C, Momin M, Omri A. Selective drug deposition in lungs through pulmonary drug delivery system for effective management of drug-resistant TB. Expert opinion on drug delivery. 2019 May 4;16(5):525-38. https://doi.org/10.1080/17425247.2019.1609937

Khan T, Sankhe K, Suvarna V, Sherje A, Patel K, Dravyakar B. DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents. Biomedicine & Pharmacotherapy. 2018 Jul 1;103: 923-38. 10.1016/j.biopha.2018.04.021